A study on presence of antibodies toTrichomonis vaginalisin serum was done on a group of 500 pregnant, asymptomatic Angolan women. A serologic screening, done by ELISA, revealed that 41% of the women had IgG and IgM against the parasite. Analysis of sera by immunoblotting revealed that 94.4% of sera with anti-T. vaginalisIgG class antibodies were reactive against a common immunogenic protein of 115 kDa. The common immunogen was identified as the protozoan α-actinin. All sera recognizing the 115-kDa antigen were reactive against both native and recombinantT. vaginalisα-actinin and nonreactive against human α-actinin. The findings presented in this work offer a new tool for epidemiologic studies and open new perspectives for vaccination.
Identification ofTrichomonas vaginalisalpha-actinin as the most common immunogen recognized by sera of women exposed to the parasite / Cappuccinelli, Pietro Antonio; Fiori, Pier Luigi; Addis, Maria Filippa; Rapelli, Paola; Pinto de Andrade, Ana Maria; Madeira Rita, Fatima; Colombo, Mauro Maria. - In: THE JOURNAL OF INFECTIOUS DISEASES. - ISSN 0022-1899. - 180:5(1999), pp. 1727-1730. [10.1086/315095]
Identification ofTrichomonas vaginalisalpha-actinin as the most common immunogen recognized by sera of women exposed to the parasite
Cappuccinelli, Pietro Antonio;Fiori, Pier Luigi;Addis, Maria Filippa;Colombo, Mauro Maria
1999-01-01
Abstract
A study on presence of antibodies toTrichomonis vaginalisin serum was done on a group of 500 pregnant, asymptomatic Angolan women. A serologic screening, done by ELISA, revealed that 41% of the women had IgG and IgM against the parasite. Analysis of sera by immunoblotting revealed that 94.4% of sera with anti-T. vaginalisIgG class antibodies were reactive against a common immunogenic protein of 115 kDa. The common immunogen was identified as the protozoan α-actinin. All sera recognizing the 115-kDa antigen were reactive against both native and recombinantT. vaginalisα-actinin and nonreactive against human α-actinin. The findings presented in this work offer a new tool for epidemiologic studies and open new perspectives for vaccination.File | Dimensione | Formato | |
---|---|---|---|
Addis_M_Articolo_1999_Identification.pdf
accesso aperto
Tipologia:
Versione editoriale (versione finale pubblicata)
Licenza:
Non specificato
Dimensione
243.55 kB
Formato
Adobe PDF
|
243.55 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.